Maximizing retention in long-term clinical trials of a weight loss agent: use of a dietitian support team
Autor: | A. Digenio, Robert Chew, S. S. Klioze, Linda M. Delahanty, R. D. England, M. Riggs |
---|---|
Rok vydání: | 2016 |
Předmět: |
medicine.medical_specialty
Nutrition and Dietetics business.industry Endocrinology Diabetes and Metabolism 030209 endocrinology & metabolism Type 2 diabetes medicine.disease Obesity Clinical trial 03 medical and health sciences 0302 clinical medicine Lifestyle modification Weight loss Weight management medicine Physical therapy Weight-Loss Agents Support system 030212 general & internal medicine medicine.symptom business |
Zdroj: | Obesity Science & Practice. 2:256-265 |
ISSN: | 2055-2238 |
DOI: | 10.1002/osp4.57 |
Popis: | SummaryObjective High-attrition rates have been observed in long-term clinical trials of weight loss agents. We evaluated the impact of an innovative retention programme on 1-year retention. Methods Three Phase 3 global multicentre clinical trials evaluated the efficacy and safety of a CB1 receptor antagonist in subjects with BMI ≥ or = 27 kg/m2. The impact of a multifaceted retention programme including a dietitian screening interview, a comprehensive culturally adapted lifestyle modification programme, and a dietitian support system to maximize lifestyle adherence, was evaluated in 4,410 subjects from four subpopulations (non-US English-speaking, non-English-speaking, US-without dietitian screening and US-with dietitian screening) comprising 208 centres from 15 countries. Results The median proportion retained over the first year among subjects in three protocols was 82%. Non-English-speaking countries showed higher retention rates (89%) compared with the USA (73%) and non-US English-speaking (81%) countries. Within the USA, behavioural screening was associated with 29% reduction in dropout rate; for every five monthly teleconferences attended above 11, there was a 32% decrease in dropout rate. Conclusions This novel retention programme greatly improved upon reported retention rates of studies conducted with other weight loss agents in long-term clinical trials. Its effectiveness should be confirmed in future trials. |
Databáze: | OpenAIRE |
Externí odkaz: |